[Application of Bevacizumab in Non-small Cell Lung Cancer].

about

[Application of Bevacizumab in Non-small Cell Lung Cancer].

Item

http://www.wikidata.org/entity/Q55556494

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@en

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@nl

type

Item

label

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@en

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@nl

prefLabel

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@en

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@nl

P1476

[Application of Bevacizumab in Non-small Cell Lung Cancer].

@en

P2093

Hongmei Li

http://www.w3.org/2001/XMLSchema#string

Ping Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials

Tumor angiogenesis: therapeutic implications

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data.

A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A.

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.

Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials.

P304

272-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2017.04.08

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28442017

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

P932

5999671

http://www.w3.org/2001/XMLSchema#string